Literature DB >> 29233889

Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization.

Shigeyuki Magi1,2, Kazunari Iwamoto1,2,3, Noriko Yumoto1, Michio Hiroshima4,5, Takeshi Nagashima6, Rieko Ohki7, Amaya Garcia-Munoz8, Natalia Volinsky8, Alexander Von Kriegsheim8, Yasushi Sako4, Koichi Takahashi3, Shuhei Kimura9, Boris N Kholodenko10,11,12, Mariko Okada-Hatakeyama13,2.   

Abstract

Feedback control is a key mechanism in signal transduction, intimately involved in regulating the outcome of the cellular response. Here, we report a novel mechanism by which PHLDA1, Pleckstrin homology-like domain, family A, member 1, negatively regulates ErbB receptor signaling by inhibition of receptor oligomerization. We have found that the ErbB3 ligand, heregulin, induces PHILDA1 expression in MCF-7 cells. Transcriptionally-induced PHLDA1 protein directly binds to ErbB3, whereas knockdown of PHLDA1 increases complex formation between ErbB3 and ErbB2. To provide insight into the mechanism for our time-course and single-cell experimental observations, we performed a systematic computational search of network topologies of the mathematical models based on receptor dimer-tetramer formation in the ErbB activation processes. Our results indicate that only a model in which PHLDA1 inhibits formation of both dimers and tetramer can explain the experimental data. Predictions made from this model were further validated by single-molecule imaging experiments. Our studies suggest a unique regulatory feature of PHLDA1 to inhibit the ErbB receptor oligomerization process and thereby control the activity of receptor signaling network.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  breast cancer; mathematical modeling; oligomerization; receptor tyrosine kinase; signal transduction

Mesh:

Substances:

Year:  2017        PMID: 29233889      PMCID: PMC5808779          DOI: 10.1074/jbc.M117.778399

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptors.

Authors:  Keiji Furuuchi; Alan Berezov; Toru Kumagai; Mark I Greene
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death.

Authors:  C G Park; S Y Lee; G Kandala; S Y Lee; Y Choi
Journal:  Immunity       Date:  1996-06       Impact factor: 31.745

3.  Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.

Authors:  Rüdiger Neef; Martina A Kuske; Elma Pröls; Judith P Johnson
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

4.  Dominant inhibition of Akt/protein kinase B signaling by the matrix protein of a negative-strand RNA virus.

Authors:  Ewan F Dunn; John H Connor
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

5.  Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.

Authors:  G C Huang; X Ouyang; R J Epstein
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

7.  ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.

Authors:  Mitchell B Berger; Jeannine M Mendrola; Mark A Lemmon
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

8.  Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis.

Authors:  Sana Basseri; Sárka Lhoták; Morgan D Fullerton; Rengasamy Palanivel; Hua Jiang; Edward G Lynn; Rebecca J Ford; Kenneth N Maclean; Gregory R Steinberg; Richard C Austin
Journal:  Diabetes       Date:  2012-09-06       Impact factor: 9.461

9.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.

Authors:  Marc R Birtwistle; Mariko Hatakeyama; Noriko Yumoto; Babatunde A Ogunnaike; Jan B Hoek; Boris N Kholodenko
Journal:  Mol Syst Biol       Date:  2007-11-13       Impact factor: 11.429

10.  TDAG51 deficiency promotes oxidative stress-induced apoptosis through the generation of reactive oxygen species in mouse embryonic fibroblasts.

Authors:  Eui-Soon Park; Juhyeok Kim; Tae-uk Ha; Jong-Soon Choi; Kwan Soo Hong; Jaerang Rho
Journal:  Exp Mol Med       Date:  2013-08-09       Impact factor: 8.718

View more
  3 in total

1.  An In Silico Analysis Identified Members of the Pleckstrin Homology-Like Domain, Family B (PHLDB family) as Potential Prognostic and Predictive Biomarkers of Treatment Response in Breast Cancer Patients.

Authors:  Renan Gomes do Nascimento; Jéssica de Moraes; Danilo de Oliveira Cerqueira; Sandro Jorge Januário
Journal:  Eur J Breast Health       Date:  2022-07-01

2.  Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1.

Authors:  Sun Young Lee; Yong Kwang Park; Cheol-Hee Yoon; Kisoon Kim; Kyung-Chang Kim
Journal:  BMC Med Genomics       Date:  2019-01-09       Impact factor: 3.063

3.  IκBα is required for full transcriptional induction of some NFκB-regulated genes in response to TNF in MCF-7 cells.

Authors:  Minami Ando; Shigeyuki Magi; Masahide Seki; Yutaka Suzuki; Takeya Kasukawa; Diane Lefaudeux; Alexander Hoffmann; Mariko Okada
Journal:  NPJ Syst Biol Appl       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.